FY2025-Annual-Report

NJAMHAA Annual Report FY 2025 7 Elsa Candelario, DSW, MSSW, LCSW Professor of Professional Practice Rutgers School of Social Work Julie Drew, MPA, LCSW Former System Executive Director Behavioral Health AtlantiCare Michele M. Eichorn, MBA, LCSW Chief Operating Officer Center for Family Services Napoleon Higgins, Jr., MD Executive Director Black Psychiatrists of America CEO Global Health Psychiatry Brigitte Johnson, Esq. President and Chief Executive Officer CarePlus NJ Erika Kerber, Esq. President/Executive Director Community Health Law Project Stephanie Marcello, PhD Assistant Vice President, Academics, Education and Innovation Rutgers University Behavioral Health Care Christopher Womack, PhD, MBA, MS, MA Community Leader Becky Wong, PharmD, MBA Medical Science Director Otsuka America Pharmaceutical, Inc. C hange the perception, impact and outcomes associated with current views of mental illness and substance use disorders. D evelop policy and educational initiatives required to create more understanding and informed actions related to mental illness and substance use disorders in key life areas such as the workplace, school and home. G ain greater recognition, acceptance, education and treatment of mental illness and substance use disorders to strengthen children and families. C onduct anti-stigma campaigns, educational activities and research. I dentify and address mental health and substance use policy issues. F ocus on identifying best practices in mental illness and substance use prevention and treatment. B uild awareness of and interest in behavioral healthcare careers and strengthen the workforce through training initiatives. At Large Members Our Priorities and Objectives